SLC16A3 and intervertebral disk degenerative disorder: This theme also highlighted the downregulation of Slc16a3, or MCT4, a plasma-membrane monocarboxylate which is essential to maintain a balance between glycolytic and TCA cycle flux as its inhibition leads to disc degeneration (Silagi et al., 2020).